Craft

OncoTherapy Science

Stock Price

¥21

2024-01-29

Market Capitalization

¥4.4 B

2024-01-29

Revenue

¥1.1 B

FY, 2023

OncoTherapy Science Summary

Company Summary

Overview
OncoTherapy Science is a company engaged in research and development of cancer therapeutics. It provides a small molecular compound for leukemia patients including acute myeloid leukemia (AML). The company also develops cancer peptide vaccines as well as antibody drugs for the treatment of refractory, relapsed, or advanced synovial sarcoma.
Type
Public
Status
Active
Founded
2001
HQ
Kawasaki, JP | view all locations
Website
https://www.oncotherapy.co.jp/en/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Kawasaki, Kanagawa HQ

    Japan

    3-chōme-2-1 Sakado, Takatsu-ku

OncoTherapy Science Financials

Summary Financials

Revenue (Q2, 2024)
¥208.3M
Gross profit (Q2, 2024)
(¥46.6M)
Net income (Q2, 2024)
(¥310.2M)
Cash (Q2, 2024)
¥881.4M
EBIT (Q2, 2024)
(¥307.1M)
Enterprise value
$3.5B

Footer menu